Q4 2025 Holdings
Filed 2026-02-17 | 76 holdings | $2.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| MacroGenics Inc(MGNX) | COM | 556099109 | $450.8K | 280,000 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $489.6K | 34,000 | 0.0% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $651.4K | 53,439 | 0.0% |
| Alector Inc(ALEC) | COM | 014442107 | $1.2M | 755,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.7M | 1,725,000 | 0.1% |
| OnKure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $1.8M | 635,000 | 0.1% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $2.1M | 870,000 | 0.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $2.3M | 120,000 | 0.1% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $2.4M | 35,000 | 0.1% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $2.8M | 243,000 | 0.1% |
| Passage Bio Inc(PASG) | COM NEW | 702712209 | $3.6M | 305,000 | 0.1% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $4.0M | 1,686,000 | 0.1% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $4.4M | 275,000 | 0.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $4.6M | 46,000 | 0.2% |
| Nyxoah SA(NYXH) | SHS | B6S7WD106 | $5.1M | 1,107,000 | 0.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $5.2M | 66,000 | 0.2% |
| DBV Technologies SA(DBVT) | SPONSORED ADS | 23306J309 | $5.8M | 300,000 | 0.2% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $5.8M | 1,475,000 | 0.2% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $6.1M | 50,000 | 0.2% |
| MapLight Therapeutics Inc(MPLT) | COM | 56565P103 | $6.8M | 385,000 | 0.2% |
| Novocure Ltd(NVCR) | ORD SHS | G6674U108 | $6.8M | 525,000 | 0.2% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $6.8M | 328,000 | 0.2% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $7.5M | 1,223,000 | 0.3% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $7.7M | 465,000 | 0.3% |
| Definium Therapeutics Inc(BRD1EUR) | COM NEW | 60255C885 | $8.5M | 637,000 | 0.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $8.8M | 325,000 | 0.3% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $9.5M | 1,055,000 | 0.3% |
| Savara Inc(SVRA) | COM | 805111101 | $9.7M | 1,606,000 | 0.3% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $10.7M | 950,000 | 0.4% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $12.2M | 775,000 | 0.4% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $13.5M | 250,000 | 0.5% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $13.5M | 150,000 | 0.5% |
| Repligen Corp(RGEN) | COM | 759916109 | $13.6M | 83,000 | 0.5% |
| Geron Corp(GERN) | COM | 374163103 | $14.9M | 11,320,000 | 0.5% |
| Penumbra Inc(PEN) | COM | 70975L107 | $15.5M | 50,000 | 0.5% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $17.6M | 2,250,000 | 0.6% |
| Crescent Biopharma Inc(CBIO) | COM | G2545C104 | $17.8M | 1,500,000 | 0.6% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $18.3M | 600,000 | 0.6% |
| Upstream Bio Inc(UPB) | COM | 91678A107 | $19.5M | 720,000 | 0.7% |
| Immunocore Holdings PLC(IMCR) | ADS | 45258D105 | $20.3M | 585,000 | 0.7% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $22.8M | 865,000 | 0.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $23.5M | 295,000 | 0.8% |
| Lantheus Holdings Inc(LNTH) | COM | 516544103 | $24.0M | 360,000 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $26.9M | 600,000 | 0.9% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $27.9M | 550,000 | 0.9% |
| KalVista Pharmaceuticals Inc(KALV) | COM | 483497103 | $30.5M | 1,890,000 | 1.0% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $30.8M | 700,000 | 1.0% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $31.6M | 1,165,000 | 1.1% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $32.8M | 5,815,000 | 1.1% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $33.7M | 1,110,000 | 1.1% |